Peripheral neuropathy associated with prolonged use of linezolid.
about
Inhibition of mammalian mitochondrial protein synthesis by oxazolidinonesLinezolid-induced optic neuropathy: a mitochondrial disorder?Rising to the challenge: new therapies for tuberculosisLinezolid for the treatment of Nocardia spp. infectionsPediatric anthrax clinical managementPeripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literatureClinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.Mitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years.Linezolid for the treatment of multidrug-resistant tuberculosis.Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.Painful neuropathy with skin denervation after prolonged use of linezolid.Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480Linezolid for the treatment of drug-resistant infections.Update on the safety of linezolid.Methicillin-resistant Staphylococcus aureus in HIV-infected patients.Changes in chest CT findings of pulmonary tuberculosis after linezolid treatment.Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia.Mycobacterium tuberculosis infection in recipients of solid organ transplants.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Role of linezolid in the treatment of orthopedic infections.Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.Update on linezolid: the first oxazolidinone antibiotic.Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.Treatment options for multidrug-resistant bacteria.Use of linezolid in children: an overview of recent advances.Investigational treatments for postoperative surgical site infections.Linezolid for the treatment of patients with central nervous system infection.New drugs and regimens for treatment of TB.World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis?Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens.Update on the appropriate use of linezolid in clinical practiceResistant pathogen-associated skin and skin-structure infections: antibiotic options.Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population.The oxazolidinones: past, present, and future.New treatment options for multidrug-resistant tuberculosis.
P2860
Q24548260-CAEE9984-A6C6-4C29-BBAC-77EC5FD57963Q24678948-FD42E37B-A743-4CAC-B431-72C96DDA9550Q27011672-1A7BF9EE-B0D6-4A95-8A09-DA96B98A991BQ28245032-A0CE4A8F-75EC-4510-95D5-188F77E4279CQ28397091-7E38C8EF-17C8-45C1-A5F7-FEF528EFDCAEQ33791908-B72D1828-E32D-446A-BE05-31FE4F974BEEQ34157657-51FF9EDE-42F6-4CA4-A124-621619D9DCC7Q34299173-91AFA39F-DD57-4BBD-BF44-E132C4D69D0BQ34348392-49F0E9DB-1FA6-419A-8FBC-08D70A67320DQ34420818-73683BF2-9C1A-4394-A8E6-C3878170D8D6Q34503844-31C70A6A-CBA8-4E2D-A136-560783625D7EQ34531604-CAC7E4FF-5457-4955-84D9-A2AE8FA8ECAEQ34656266-4DDD9538-C993-416E-8497-2FBDD3345DA9Q34737298-E1E0B6C4-574F-4CA9-A82A-903B31DB7FCCQ34894133-4D1CB952-22B4-4C8A-A623-2542A1FA640EQ34987632-F048E3DD-8516-42D9-81EA-B9158DE7E260Q35026548-1C7CA99F-EF6C-4976-B367-A2A6940845F4Q35059096-983E1ACE-3780-4148-A161-69DB58EC912EQ35568367-DFBD9CDC-C161-4A9F-B97B-12B7ECD29F6AQ35647719-298E8D30-BDD3-48B8-9C50-64E4A01D2FFFQ36042599-F40E33B3-C47F-49ED-8D28-F6F06102C803Q36083208-9884F678-93F1-44EC-A698-40605EB868E8Q36162348-A97E4C3E-7F3B-4CCE-8C3E-E88E896594CBQ36283731-96447801-415A-4B2D-B663-99B41BD951E5Q36283744-0247D29A-8F3F-42E3-B74B-922D04429E87Q36402705-D1EBE5B0-F1BE-4113-BC69-3F5F1148902DQ36545088-B3C447DB-3D3F-4B2D-8253-07ADEB8D1FABQ36607401-703CA852-66BF-4AFA-92B5-1BADA7091FA6Q36688930-8F40766D-2B7C-41B7-A15E-E570953E8168Q36715742-B60E0F67-4819-4B4C-AE8F-0FE550EC7096Q36729811-07B8EB0B-AFD0-4790-AD7A-B905D13973E0Q36825354-D3DD6980-A3FC-4343-9AB3-F0FC6DB02578Q36957270-569B8516-E513-4092-8639-E59110327C65Q36969745-1847692B-0790-48F1-918D-F4646D41A12BQ37071199-6D2824FA-3265-4260-8FA1-F0E5AB2CBCAEQ37116859-0E0D93E1-965A-4B7A-B0D1-ABEB3610938EQ37785546-99B0CA64-F579-4A80-94CE-954EB3D21141Q37809636-B0613742-556B-4F79-8910-0C9173570FA6Q37970719-AF692E0F-27D6-4656-85C2-F9BF8F7E7C76Q38024041-697D2DC9-3338-44E8-B3C3-40FAA20B81D7
P2860
Peripheral neuropathy associated with prolonged use of linezolid.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Peripheral neuropathy associated with prolonged use of linezolid.
@ast
Peripheral neuropathy associated with prolonged use of linezolid.
@en
Peripheral neuropathy associated with prolonged use of linezolid.
@nl
type
label
Peripheral neuropathy associated with prolonged use of linezolid.
@ast
Peripheral neuropathy associated with prolonged use of linezolid.
@en
Peripheral neuropathy associated with prolonged use of linezolid.
@nl
prefLabel
Peripheral neuropathy associated with prolonged use of linezolid.
@ast
Peripheral neuropathy associated with prolonged use of linezolid.
@en
Peripheral neuropathy associated with prolonged use of linezolid.
@nl
P2093
P1476
Peripheral neuropathy associated with prolonged use of linezolid.
@en
P2093
Adam M Bressler
Jane L Gilmore
Jyoti Somani
Shanta M Zimmer
P304
P356
10.1016/S1473-3099(04)01109-0
P577
2004-08-01T00:00:00Z